An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

As a high school teacher and baseball coach, Steve Loutzenhiser is used to an active life, describing himself as “super ...

Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...

Hello Health Rounds Readers! Today we feature a study that found seniors may be less vulnerable to bird flu than younger adults and children. We also report on studies that could lead to practice ...

Explore the unexpected factors that may influence brain tumor risk and learn practical steps to protect your health and well-being.

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, PhD, Ward-Coleman Chair in Cancer ...

Bill Crane, a longtime political strategist and commentator for Channel 2 Action News, has been diagnosed with what he called an “aggressive” form of colon cancer. Crane had surgery last week to ...